| Ytd | -37.82% | |
| 1y | -3.56% |
| Open | 4.33 | Prev Close | 4.34 | Low | 4.17 | High | 4.33 | Mkt Cap | 164.53M |
| Vol | 1.68K | Avg Vol | 481.40K | EPS | -1.68 | P/E | -2.58 | Forward P/E | -3.50 |
| Beta | 0.43 | Short Ratio | 2.38 | Inst. Own | 17.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.82 | 200-d Avg | 4.79 | 1yr Est | 11.64 |
TLSI News
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li
TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technolo
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology compan
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigat
ATLANTA, June 05, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether TriSalus Li
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES--(BUSINESS WIRE)---- $TLSI--TLSI Investors Have Opportunity to Join TriSalus Life Scienc
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it ha
TriSalus Life Sciences Inc. reaffirmed $60-$62 million revenue guidance on March 5, 2026. Months lat
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, to
US stocks mixed, Nasdaq up 200 points. Dow down 0.43%, Nasdaq up 0.79%, S&P 500 up 0.27%. Commun
US stocks mixed as Dow drops over 200 points on opening. Nasdaq up 0.13%, S&P 500 down 0.13%. Te
